Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10871642 | PMC |
| http://dx.doi.org/10.1097/JS9.0000000000000932 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Editorial comment on the Role of cytoreductive nephrectomy in the era of immune checkpoint inhibitors: A review of current evidence and ongoing trials.
Int J Urol
January 2025
Department of Urology, Teikyo University Chiba Medical Center, Ichihara, Chiba Prefecture, Japan.
Bowel Resection Outcomes in Ovarian Cancer Cytoreductive Surgery by Surgeon Specialty.
JAMA Surg
October 2024
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Tufts University School of Medicine, Boston, Massachusetts.
Importance: Extensive bowel surgery is often necessary to achieve complete cytoreduction in patients with epithelial ovarian cancer. Regardless of who performs the surgery, it has been well documented that bowel resections are a high-risk procedure and an anastomotic leak is a severe complication that can occur. There are few studies addressing whether surgeon type impacts surgical outcomes in this patient population.
View Article and Find Full Text PDFSurgical management of metastatic neuroendocrine tumors: beyond the realm of evidence-based medicine.
Hepatobiliary Surg Nutr
June 2024
Department of Gastrointestinal Oncology, Moffitt Cancer Center & Research Institute, University of South Florida, Tampa, FL, USA.
The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the modern era.
Transl Androl Urol
May 2024
Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Human tissue-resident peritoneal macrophages reveal resistance towards oxidative cell stress induced by non-invasive physical plasma.
Front Immunol
March 2024
Department of Women's Health Tübingen, University of Tübingen, Tübingen, Germany.
Article Synopsis
- * Research is looking into plasma-activated liquids (PAL) as a potential adjuvant treatment to reduce side effects and protect healthy tissue during peritoneal cancer therapy.
- * Studies showed that human peritoneal macrophages exposed to PAL displayed resistance by increasing proliferation and anti-oxidative pathways, suggesting PAL might have beneficial immunomodulatory effects for treating peritoneal cancer.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!